Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model
出版年份 2013 全文链接
标题
Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model
作者
关键词
-
出版物
PLoS Computational Biology
Volume 9, Issue 3, Pages e1002959
出版商
Public Library of Science (PLoS)
发表日期
2013-03-15
DOI
10.1371/journal.pcbi.1002959
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Modeling Quasispecies and Drug Resistance in Hepatitis C Patients Treated with a Protease Inhibitor
- (2012) Libin Rong et al. BULLETIN OF MATHEMATICAL BIOLOGY
- Anti−Hepatitis C Virus Drugs in Development
- (2012) Esperance A.K. Schaefer et al. GASTROENTEROLOGY
- Understanding silibinin’s modes of action against HCV using viral kinetic modeling
- (2012) Jeremie Guedj et al. JOURNAL OF HEPATOLOGY
- A Viral Dynamic Model for Treatment Regimens with Direct-acting Antivirals for Chronic Hepatitis C Infection
- (2012) Bambang S. Adiwijaya et al. PLoS Computational Biology
- Novel Therapies for Hepatitis C: Insights from the Structure of the Virus
- (2011) Dahlene N. Fusco et al. Annual Review of Medicine
- Virologic Escape during Danoprevir (ITMN-191/RG7227) Monotherapy Is Hepatitis C Virus Subtype Dependent and Associated with R155K Substitution
- (2011) Sharlene R. Lim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Second-wave Protease Inhibitors: Choosing an Heir
- (2011) Sandra Ciesek et al. Clinics in Liver Disease
- 776 MODELING INTERFERON-ALPHA MEDIATED INHIBITION KINETICS OF INTRACELLULAR AND EXTRACELLULAR HCVRNA DURING HCV INFECTION IN VITRO
- (2011) H. Dahari et al. JOURNAL OF HEPATOLOGY
- Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients
- (2011) Edward J. Gane et al. JOURNAL OF HEPATOLOGY
- Antiviral Activity of Danoprevir (ITMN-191/RG7227) in Combination With Pegylated Interferon α-2a and Ribavirin in Patients With Hepatitis C
- (2011) Nicole Forestier et al. JOURNAL OF INFECTIOUS DISEASES
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Comprehensive Hepatitis C Viral Kinetic Model Explaining Cure
- (2010) E Snoeck et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Protease Inhibitor–Resistant Hepatitis C Virus Mutants With Reduced Fitness From Impaired Production of Infectious Virus
- (2010) Tetsuro Shimakami et al. GASTROENTEROLOGY
- Pharmacodynamics of PEG-IFN-α-2a in HIV/HCV co-infected patients: Implications for treatment outcomes
- (2010) Harel Dahari et al. JOURNAL OF HEPATOLOGY
- Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis
- (2010) Ana-Carolina Cardoso et al. JOURNAL OF HEPATOLOGY
- Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: A phase 1b multiple ascending dose study
- (2010) Nicole Forestier et al. JOURNAL OF HEPATOLOGY
- Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics
- (2010) J. Guedj et al. JOURNAL OF THEORETICAL BIOLOGY
- A perspective on modelling hepatitis C virus infection
- (2010) J. Guedj et al. JOURNAL OF VIRAL HEPATITIS
- Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
- (2010) Edward J Gane et al. LANCET
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
- (2010) L. Rong et al. Science Translational Medicine
- A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants
- (2010) Bambang S. Adiwijaya et al. PLoS Computational Biology
- Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials
- (2009) Tahany Awad et al. HEPATOLOGY
- Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon
- (2009) H. Dahari et al. JOURNAL OF VIROLOGY
- A Step Forward in Therapy for Hepatitis C
- (2009) Jay H. Hoofnagle NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
- (2009) Christophe Hézode et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now